Skip to main content
. 2021 Jan 21;59(2):e02342-20. doi: 10.1128/JCM.02342-20

FIG 1.

FIG 1

Serum collection used for the evaluation. (A) Distribution of 250 serum samples from COVID-positive patients according to the number of days after the onset of symptoms. (B) Distribution of the 254 control serum samples.